Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT00896935
  4. Details
NCT00896935 Clinical Trial

Arizona Cancer Center Biospecimen Repository

Cancer Clinical Trial

Official title:
Arizona Cancer Center Biospecimen Repository

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT00896935
Other study ID # CDR0000597579
Secondary ID P30CA023074UARIZ
Status Recruiting
Phase
First received
Last updated
Start date July 2006
Est. completion date July 2030

Study information
Verified date August 2023
Source University of Arizona
Contact Arizona Cancer Center at University of Arizona Health Sciences
Phone 520-626-0950
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Description:

OBJECTIVES: - Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer. - Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine. - Provide quality-controlled storage and management of the specimen bank. - Collect relevant clinical and pathologic information with appropriate privacy protection. - Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings. OUTLINE: This is a multicenter study. Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

Recruitment information / eligibility
Status Recruiting
Enrollment 10000
Est. completion date July 2030
Est. primary completion date July 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS: - Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer PATIENT CHARACTERISTICS: - NA PRIOR CONCURRENT THERAPY: - NA As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• biologic sample preservation procedure
biologic sample preservation procedure

Locations
Country Name City State
United States Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona

Sponsors (2)
Lead Sponsor Collaborator
University of Arizona National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Provision of tissue samples and biospecimens for translational study An electronic record of the specimens is kept in a secure, web-based database. Follow-up information from patients will be obtained from the patient medical record, and updated every 6 months July 2024
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links